{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:54:53Z","timestamp":1794621293846,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study aimed to investigate treatment strategies determining additional treatment after endoscopic resection (ER) of rectal neuroendocrine tumor (NET)s and long-term outcomes of endoscopically resected rectal NETs. We analyzed a total of 322 patients medical records of patients who underwent ER for rectal NETs. Rectal NETs initially resected as polyps and treated with conventional endoscopic mucosal resection (EMR) were observed more frequently in the non-curative group (<jats:italic>P<\/jats:italic>\u2009=\u20090.041 and <jats:italic>P<\/jats:italic>\u2009=\u20090.012, respectively). After ER, only 44 of the 142 patients (31.0%) who did not meet the criteria for curative resection received additional salvage treatment. In multivariate analysis, lesions diagnosed via biopsies (OR, 0.096; <jats:italic>P<\/jats:italic>\u2009=\u20090.002) or suspected as NETs initially (OR, 0.04; <jats:italic>P<\/jats:italic>\u2009=\u20090.001) were less likely to undergo additional treatment. Positive lymphovascular invasion (OR 61.971; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), positive (OR 75.993; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), or indeterminate (OR 13.203; <jats:italic>P<\/jats:italic>\u2009=\u20090.001) resection margins were more likely to undergo additional treatment. Although lymph node metastasis was found in 6 patients, none experienced local or metastatic tumor recurrence during the median follow-up of 40.49 months. Long-term outcomes after ER for rectal NETs were excellent. The prognosis showed favorable outcomes regardless of whether patients receive additional salvage treatments.<\/jats:p>","DOI":"10.1038\/s41598-019-40668-6","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T11:03:45Z","timestamp":1553079825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors"],"prefix":"10.1038","volume":"9","author":[{"given":"Jae Hwang","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Hyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Jin","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-890X","authenticated-orcid":false,"given":"Tae Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"key":"40668_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/BF02050318","volume":"35","author":"AB Jetmore","year":"1992","unstructured":"Jetmore, A. B. et al. Rectal carcinoids: the most frequent carcinoid tumor. Diseases of the colon and rectum 35, 717\u2013725 (1992).","journal-title":"Diseases of the colon and rectum"},{"key":"40668_CR2","first-page":"429","volume":"74","author":"RG Robertson","year":"2006","unstructured":"Robertson, R. G., Geiger, W. J. & Davis, N. B. Carcinoid tumors. American family physician 74, 429\u2013434 (2006).","journal-title":"American family physician"},{"key":"40668_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin, I. M., Lye, K. D. & Kidd, M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97, 934\u2013959, https:\/\/doi.org\/10.1002\/cncr.11105 (2003).","journal-title":"Cancer"},{"key":"40668_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin, I. M. et al. Gastroenteropancreatic neuroendocrine tumours. The Lancet. Oncology 9, 61\u201372, https:\/\/doi.org\/10.1016\/s1470-2045(07)70410-2 (2008).","journal-title":"The Lancet. Oncology"},{"key":"40668_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.surg.2008.05.005","volume":"144","author":"CS Landry","year":"2008","unstructured":"Landry, C. S., Brock, G., Scoggins, C. R., McMasters, K. M. & Martin, R. C. 2nd A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients. Surgery 144, 460\u2013466, https:\/\/doi.org\/10.1016\/j.surg.2008.05.005 (2008).","journal-title":"Surgery"},{"key":"40668_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-0028-1119456","volume":"41","author":"H Scherubl","year":"2009","unstructured":"Scherubl, H. Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy 41, 162\u2013165, https:\/\/doi.org\/10.1055\/s-0028-1119456 (2009).","journal-title":"Endoscopy"},{"key":"40668_CR7","first-page":"231","volume":"179","author":"S Mani","year":"1994","unstructured":"Mani, S., Modlin, I. M., Ballantyne, G., Ahlman, H. & West, B. Carcinoids of the rectum. Journal of the American College of Surgeons 179, 231\u2013248 (1994).","journal-title":"Journal of the American College of Surgeons"},{"key":"40668_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1245\/s10434-006-9197-3","volume":"14","author":"BN Fahy","year":"2007","unstructured":"Fahy, B. N. et al. Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Annals of surgical oncology 14, 396\u2013404, https:\/\/doi.org\/10.1245\/s10434-006-9197-3 (2007).","journal-title":"Annals of surgical oncology"},{"key":"40668_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/gut.2006.109157","volume":"56","author":"T Konishi","year":"2007","unstructured":"Konishi, T. et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut 56, 863\u2013868, https:\/\/doi.org\/10.1136\/gut.2006.109157 (2007).","journal-title":"Gut"},{"key":"40668_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000335594","volume":"95","author":"M Caplin","year":"2012","unstructured":"Caplin, M. et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 95, 88\u201397, https:\/\/doi.org\/10.1159\/000335594 (2012).","journal-title":"Neuroendocrinology"},{"key":"40668_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1055\/s-0033-1344794","volume":"45","author":"L de Mestier","year":"2013","unstructured":"de Mestier, L., Brixi, H., Gincul, R., Ponchon, T. & Cadiot, G. Updating the management of patients with rectal neuroendocrine tumors. Endoscopy 45, 1039\u20131046, https:\/\/doi.org\/10.1055\/s-0033-1344794 (2013).","journal-title":"Endoscopy"},{"key":"40668_CR12","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00535-015-1079-7","volume":"50","author":"M Sekiguchi","year":"2015","unstructured":"Sekiguchi, M. et al. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion. Journal of gastroenterology 50, 1184\u20131189, https:\/\/doi.org\/10.1007\/s00535-015-1079-7 (2015).","journal-title":"Journal of gastroenterology"},{"key":"40668_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/00365521.2015.1107752","volume":"51","author":"K Nakamura","year":"2016","unstructured":"Nakamura, K. et al. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification. Scandinavian journal of gastroenterology 51, 448\u2013455, https:\/\/doi.org\/10.3109\/00365521.2015.1107752 (2016).","journal-title":"Scandinavian journal of gastroenterology"},{"key":"40668_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/apt.13697","volume":"44","author":"R Basuroy","year":"2016","unstructured":"Basuroy, R., Haji, A., Ramage, J. K., Quaglia, A. & Srirajaskanthan, R. Review article: the investigation and management of rectal neuroendocrine tumours. Alimentary pharmacology & therapeutics 44, 332\u2013345, https:\/\/doi.org\/10.1111\/apt.13697 (2016).","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"40668_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amjsurg.2016.01.008","volume":"211","author":"YJ McConnell","year":"2016","unstructured":"McConnell, Y. J. Surgical management of rectal carcinoids: trends and outcomes from the Surveillance, Epidemiology, and End Results database (1988 to 2012). American journal of surgery 211, 877\u2013885, https:\/\/doi.org\/10.1016\/j.amjsurg.2016.01.008 (2016).","journal-title":"American journal of surgery"},{"key":"40668_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/cncr.20939","volume":"103","author":"J Soga","year":"2005","unstructured":"Soga, J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 103, 1587\u20131595, https:\/\/doi.org\/10.1002\/cncr.20939 (2005).","journal-title":"Cancer"},{"key":"40668_CR17","doi-asserted-by":"publisher","first-page":"16252","DOI":"10.3748\/wjg.v20.i43.16252","volume":"20","author":"Y Chi","year":"2014","unstructured":"Chi, Y., Du, F., Zhao, H., Wang, J. W. & Cai, J. Q. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors. World J Gastroenterol 20, 16252\u201316257, https:\/\/doi.org\/10.3748\/wjg.v20.i43.16252 (2014).","journal-title":"World J Gastroenterol"},{"key":"40668_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/den.12232","volume":"26","author":"JH Jeon","year":"2014","unstructured":"Jeon, J. H. et al. Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors. Dig Endosc 26, 556\u2013563, https:\/\/doi.org\/10.1111\/den.12232 (2014).","journal-title":"Dig Endosc"},{"key":"40668_CR19","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3748\/wjg.v19.i16.2555","volume":"19","author":"FR Zhou","year":"2013","unstructured":"Zhou, F. R., Huang, L. Y. & Wu, C. R. Endoscopic mucosal resection for rectal carcinoids under micro-probe ultrasound guidance. World J Gastroenterol 19, 2555\u20132559, https:\/\/doi.org\/10.3748\/wjg.v19.i16.2555 (2013).","journal-title":"World J Gastroenterol"},{"key":"40668_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/ajg.2016.267","volume":"111","author":"CM Moon","year":"2016","unstructured":"Moon, C. M. et al. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study. The American journal of gastroenterology 111, 1276\u20131285, https:\/\/doi.org\/10.1038\/ajg.2016.267 (2016).","journal-title":"The American journal of gastroenterology"},{"key":"40668_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1055\/s-0030-1256414","volume":"43","author":"CH Park","year":"2011","unstructured":"Park, C. H. et al. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. Endoscopy 43, 790\u2013795, https:\/\/doi.org\/10.1055\/s-0030-1256414 (2011).","journal-title":"Endoscopy"},{"key":"40668_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1055\/s-0033-1344860","volume":"45","author":"GU Kim","year":"2013","unstructured":"Kim, G. U. et al. Clinical outcomes of rectal neuroendocrine tumors<\/=10 mm following endoscopic resection. Endoscopy 45, 1018\u20131023, https:\/\/doi.org\/10.1055\/s-0033-1344860 (2013).","journal-title":"Endoscopy"},{"key":"40668_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/MEG.0b013e3283551e0b","volume":"24","author":"HY Sung","year":"2012","unstructured":"Sung, H. Y. et al. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution. Eur J Gastroen Hepat 24, 978\u2013983, https:\/\/doi.org\/10.1097\/MEG.0b013e3283551e0b (2012).","journal-title":"Eur J Gastroen Hepat"},{"key":"40668_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.6004\/jnccn.2012.0075","volume":"10","author":"MH Kulke","year":"2012","unstructured":"Kulke, M. H. et al. Neuroendocrine tumors. J Natl Compr Canc Netw 10, 724\u2013764 (2012).","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40668-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:56:35Z","timestamp":1671263795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40668-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["40668"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-40668-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4911"}}